Novi-Beograd, Serbia Clinical Trials

A listing of Novi-Beograd, Serbia clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia

To evaluate the long-term safety and tolerability of pimavanserin after 52 weeks of adjunctive treatment in subjects with schizophrenia

brexpiprazole
risperidone
adjunctive treatment
lurasidone
cariprazine
Clinic for Psychiatric Diseases "Dr Laza Lazarevic"
 (3.7 away) Contact site
  • 240 views
  • 29 Jan, 2021
  • +151 other locations
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medicine). The study will be performed in people with type 2 diabetes. Participants will either get semaglutide or placebo in addition to their diabetes medicines - which treatment the …

semaglutide
hypoglycemic agents
Novo Nordisk Investigational Site
 (3.7 away) Contact site
  • 581 views
  • 25 Jul, 2021
  • +237 other locations
A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of anamorelin HCl. Approximately 316 patients with advanced NSCLC with cachexia will be randomized 1:1 to anamorelin HCl 100 mg or placebo, taken orally once daily (QD) for a total of 24 weeks. Patients will be instructed to …

renal function
anamorelin hydrochloride
kidney function test
metastasis
body mass index
Clinical Center of Serbia, Clinic of Pulmonology
 (3.7 away) Contact site
  • 197 views
  • 05 Jul, 2021
  • +72 other locations
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis Post Polycythemia Vera Myelofibrosis or Post-Essential Thrombocythemia Myelofibrosis

This study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count <50,000/L). Approximately 348 patients in total will be enrolled, randomized 2:1 to either pacritinib (approximately 232 patients) or …

essential thrombocythemia
left upper quadrant pain
renal function
blood blast count
platelet count
Clinical Center of Serbia, Clinic of Hematology
 (3.7 away) Contact site
  • 506 views
  • 19 Jul, 2021
  • +177 other locations
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

mirikizumab
Clinical Center Zemun
 (3.2 away) Contact site
  • 1722 views
  • 24 Jul, 2021
  • +880 other locations
A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive With or Without Mixed Features

To evaluate the efficacy and safety of cariprazine at a target dose of 3.0 mg/d compared with placebo in prevention of relapse in patients with bipolar I disorder whose current episode (i.e. index episode) is manic or depressive, with or without mixed features; 2) To evaluate the efficacy and safety …

psychiatric disorder
bipolar i disorder
cariprazine
tension
mania
Clinic of Psychiatric Diseases - Dr. Laza Lazarevic
 (3.7 away) Contact site
  • 8584 views
  • 01 Aug, 2021
  • +269 other locations
Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome

This is a phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of CSL112 on reducing the risk of major adverse CV events [MACE - cardiovascular (CV) death, myocardial infarction (MI), and stroke] in subjects with acute coronary syndrome (ACS) diagnosed with either ST-segment elevation …

acute coronary syndrome
stemi
stroke
diabetes
percutaneous coronary intervention
6880014 - Klini ki Centar Srbije
 (3.7 away) Contact site
  • 1118 views
  • 01 Aug, 2021
  • +3430 other locations
A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease. Participants will either get semaglutide tablets or placebo tablets ("dummy" medicine) - which treatment is decided by chance. Participants must take one tablet with water every morning on …

semaglutide
chronic disease
stroke
Novo Nordisk Investigational Site
 (3.7 away) Contact site
  • 1276 views
  • 01 Aug, 2021
  • +557 other locations
A Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to see if the study drug mirikizumab is safe and effective in participants with moderately to severely active Crohn's disease.

ustekinumab
crohn's disease
Clinical Center Zemun
 (3.0 away) Contact site
  • 646 views
  • 25 Jul, 2021
  • +991 other locations
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blinded treatment (either etrasimod 2 mg per day or placebo) during participation in one of two Phase 3 double-blinded, placebo-controlled …

Clinical Center " Dr Dragisa Misovic Dedinje"
 (3.7 away) Contact site
  • 133 views
  • 02 Aug, 2021
  • +391 other locations